Development of improved formulations or delivery systems could potentially enhance therapeutic efficacy, reduce dosing frequency, or improve patient compliance with treatment protocols
Retrieved from Diz-Chaves, Y., Herrera-Prez, S., Gonzlez-Matas, L
Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in yukon, northwest territories, and nunavut
reported that the stable expression of the GCGR in human embryonic kidney 293 cells led to similar increases in cAMP and intracellular Ca 2+ levels in response to glucagon treatment, and dose-dependent activation of ERK1/2 (30), highlighting the GCGR-dependent nature of the effect
30
Most of the TmGsts were predicted by the WolF PSORT to localize in cytoplasm (9 out of 20 proteins), followed by mitochondria, and nucleus (Fig